Total Raised

$400K

Investors Count

5

Funding, Valuation & Revenue

1 Fundings

Capabiliti has raised $400K over 1 rounds.

Capabiliti's latest funding round was a Seed VC for $0.4M on September 24, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/24/2015

Seed VC

$0.4M

$XXM

0

FY undefined

1

Date

9/24/2015

Round

Seed VC

Amount

$0.4M

Investors

Valuation

$XXM

Revenue

0

FY undefined

Sources

1

Start free trial
New call-to-action

Capabiliti Investors

5 Investors

Capabiliti has 5 investors. 500 Global invested in Capabiliti's Seed VC funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/24/2015

9/24/2015

1
Seed VC

Venture Capital

California

00/00/0000

00/00/0000

Kunal Bahl

Subscribe to see more

Angel Investor (Individual)

00/00/0000

00/00/0000

Rohit Bansal

Subscribe to see more

Angel Investor (Individual)

00/00/0000

00/00/0000

Smile Group

Subscribe to see more

Holding Company

India

00/00/0000

00/00/0000

Girish Mathrubootham

Subscribe to see more

Angel Investor (Individual)

First funding

9/24/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

9/24/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Kunal Bahl

Rohit Bansal

Smile Group

Girish Mathrubootham

Rounds

1
Seed VC

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Angel Investor (Individual)

Angel Investor (Individual)

Holding Company

Angel Investor (Individual)

Location

California

India

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.